The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback